The FDA this week granted its first full approval for a Covid-19 drug to an antiviral called remdesivir.
— Vox (@voxdotcom) October 24, 2020
But scientists are concerned that evidence for its effectiveness is mixed and the drug needs more examination. https://t.co/Q0uyjgcwm9
FDA's first COVID-19 treatment Gilead's remdesivir: 5 fast facts https://t.co/TGOjeDV0wH
— Ryan Petty (@rpetty) October 23, 2020
This piece points out some really important and disturbing issues with the remdesivir FDA approval. (thread) https://t.co/ZcmnmESLpx
— Robbie Goldstein (@RobbieForChange) October 24, 2020
The FDA approved remdesivir to treat Covid-19. Scientists are questioning the evidence. ?https://t.co/2o4dn2SUp9
— 2021_ Free of you know who ? ? (@2021_free) October 24, 2020